February 2020
Richard P. Ebstein Professor: C2BEF (China Center for Behavior Economics and Finance), Sourthwestern University of Finance and Economics, Chengdu, China Professor: Zhejiang University of Technology, College of Economics and Management
DEGREES/DIPLOMAS/PROFESSIONAL QUALIFICATION 1963 BSc Union College, Schenectady, New York 1965 MS Yale University, New Haven 1968 PhD Yale University, New Haven
PREVIOUS EMPLOYMENT 1968 1972 Lecturer, Hebrew University, Rehovot 1972 1973 Assistant Professor, New York University Medical Center 1972 1974 Assistant Research Scientist, New York University Medical Center 1974 1982 Senior Scientist, Herzog-Ezrat Nashim Hospital 1980 1981 Visiting Expert, National Institutes of Health, Bethesda 1982 2010 Director of Research & Clinical Lab, Sarah Herzog-(Ezrath Nashim) Hospital 1991 1992 DAAD Fellow, Dept of Neurochemistry, Munich, Germany 1997 2002 Professor (Chaver-Adjunct), Ben-Gurion University 2001 2002 Visiting Professor, Hebrew University 2002 2010 Professor, Hebrew University 2010 2018 Professor, National University of Singapore
CITATION ANALYSIS
All Since 2014
Citations 28076 11207
h-index 88 53
i10-index 323 177
PUBLICATIONS Relating to Behavioral and Biological Economics and the Social Sciences 1. Y. Huang et al., “Successful aging, cognitive function, socioeconomic status, and leukocyte telomere length,” Psychoneuroendocrinology, vol. 103, pp. 180–187, 2019. 2. Zhong S, Shalev I, Koh D, Ebstein RP, Chew SH. Competitiveness and stress. Int Econ Rev (Philadelphia). 2018;59(3):1263-1281. 3. Yim O-S, Zhang X, Shalev I, Monakhov M, Zhong S, Hsu M, et al. Delay discounting, genetic sensitivity, and leukocyte telomere length. Proc Natl Acad Sci U S A. 2016;113(10). 4. Shen Q, Teo M, Winter E, Hart E, Chew SH, Ebstein RP. To cheat or not to cheat: Tryptophan hydroxylase 2 SNP variants contribute to dishonest behavior. Front Behav Neurosci. 2016;10(MAY). 5. Ebstein RP, Monakhov MV, Lu Y, Jiang Y, Lai PS, Chew SH. Association between the dopamine D4 receptor gene exon III variable number of tandem repeats and political attitudes in female Han Chinese. Proc R Soc B Biol Sci. 2015;282(1813). 6. Jiang Y, Bachner-Melman R, Chew SH, Ebstein RP. Dopamine D4 receptor gene and religious affiliation correlate with dictator game altruism in males and not females: Evidence for gender-sensitive gene ? culture interaction. Front Neurosci. 2015;9(SEP). 7. Set E, Saez I, Zhu L, Houser DE, Myung N, Zhong S, et al. Dissociable contribution of prefrontal and striatal dopaminergic genes to learning in economic games. Proc Natl Acad Sci U S A. 2014;111(26). 8. Chew SH, Ebstein RP, Zhong S. Sex-hormone genes and gender difference in ultimatum game: Experimental evidence from China and Israel. J Econ Behav Organ. 2013;90. 9. Eisenegger C, Pedroni A, Rieskamp J, Zehnder C, Ebstein R, Fehr E, et al. DAT1 Polymorphism Determines L-DOPA Effects on Learning about Others’ Prosociality. PLoS One. 2013;8(7). 10. Chew SH, Ebstein RP, Zhong S. Ambiguity aversion and familiarity bias: Evidence from behavioral and gene association studies. J Risk Uncertain. 2012;44(1). 11. Gianotti LRR, Figner B, Ebstein RP, Knoch D. Why some people discount more than others: Baseline activation in the dorsal PFC mediates the link between COMT genotype and impatient choice. Front Neurosci. 2012;(MAY). 12. Israel S, Weisel O, Ebstein RP, Bornstein G. Oxytocin, but not vasopressin, increases both parochial and universal altruism. Psychoneuroendocrinology. 2012;37(8). 13. Zhong S, Chark R, Ebstein RP, Chew SH. Imaging genetics for utility of risks over gains and losses. Neuroimage. 2012;59(1). 14. Zhong S, Monakhov M, Mok HP, Tong T, Lai PS, Chew SH, et al. U-Shaped Relation between Plasma Oxytocin Levels and Behavior in the Trust Game. PLoS One. 2012;7(12). 15. Avinun R, Israel S, Shalev I, Gritsenko I, Bornstein G, Ebstein RP, et al. Avpr1a variant associated with preschoolers’ lower altruistic behavior. PLoS One. 2011;6(9). 16. Ebstein R, Shamay-Tsoory S, Chew SH. From DNA to Social Cognition. From DNA to Social Cognition. 2011. Wiley-Blackwell. Hoboken NJ. ISBN-10: 0470543965. 17. Ebstein RP, Israel S, Chew SH, Zhong S, Knafo A. Genetics of Human Social Behavior. Neuron. 2010;65(6). 18. Eisenegger C, Knoch D, Ebstein RP, Gianotti LRR, S?ndor PS, Fehr E. Dopamine Receptor D4 Polymorphism Predicts the Effect of L-DOPA on Gambling Behavior. Biol Psychiatry. 2010;67(8). 19. Zhong S, Israel S, Shalev I, Xue H, Ebstein RP, Chew SH. Dopamine D4 receptor gene associated with fairness preference in ultimatum game. PLoS One. 2010;5(11). 20. Israel S, Lerer E, Shalev I, Uzefovsky F, Riebold M, Laiba E, et al. The oxytocin receptor (OXTR) contributes to prosocial fund allocations in the Dictator Game and the social value orientations task. PLoS One. 2009;4(5). 21. Zhong S, Chew SH, Set E, Zhang J, Xue H, Sham PC, et al. The heritability of attitude toward economic risk. Twin Res Hum Genet. 2009;12(1). 22. Zhong S, Israel S, Xue H, Ebstein RP, Chew SH. Monoamine oxidase A gene (MAOA) associated with attitude towards longshot risks. PLoS One. 2009;4(12). 23. Zhong S, Israel S, Xue H, Sham PC, Ebstein RP, Chew SH. A neurochemical approach to valuation sensitivity over gains and losses. Proc R Soc B Biol Sci. 2009;276(1676). 24. Israel S, Lerer E, Shalev I, Uzefovsky F, Reibold M, Bachner-Melman R, et al. Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between. Vol. 170, Progress in Brain Research. 2008. 25. Knafo A, Israel S, Darvasi A, Bachner-Melman R, Uzefovsky F, Cohen L, et al. Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes, Brain Behav. 2008;7(3).
Year 2019-2020
1. Lev-Ari, L., Bachner-Melman, R., Zohar, A. H., Ebstein, R., & Mankuta, D. (2020). Weight gain, feeding and eating in the first year of life of babies of smoking and non- smoking mothers. Early Human Development, 140, 104889. 2. Huang, Y., Siong, Y. O., Lai, P. S., Yu, R., Chew, S. H., Gwee, X., Nyunt, M. S. Z., Gao, Q., Ng, T. P., Ebstein, R. P., Gouin, J.-P., Yim, O. S., San Lai, P., Yu, R., Chew, S. H., Gwee, X., Nyunt, M. S. Z., Gao, Q., Ng, T. P., & Ebstein, R. P. (2019). Successful aging, cognitive function, socioeconomic status, and leukocyte telomere length. Psychoneuroendocrinology, 103, 180–187 3. Liu, C., Xu, L., Li, J., Zhou, F., Yang, X., Zheng, X., Fu, M., Li, K., Sindermann, C., & Montag, C. (2019). Serotonin and childhood maltreatment interact to shape brain architecture and anxious avoidant behavior–a TPH2 imaging genetics approach. BioRxiv, 685099. 4. Xiaolei Xua, Jing Daia, Congcong Liua, Yuanshu Chena, Fei Xina, Feng Zhoua, Xinqi Zhoua, Yulan Huang, Jinyu Wang, Zhili Zouc, Jialin Lia, Richard P. Ebstein, Keith M. Kendricka Bo Zhouc Benjamin Beckera (2019). Common and Disorder-Specific Neurofunctional Markers of Dysregulated Empathic Reactivity in Major Depression and Generalized Anxiety Disorder. Psychotherapy and Psychosomatics, 1. https://doi.org/10.1159/0005041805. 5. Lei Wang, Lu Li, Qiang Shen,Jiehui Zheng, Richard P. Ebstein. To run with the herd or not: Electrophysiological dynamics predict social-sensitive preference change in crowdfunding. Neuropsychologia IN PRESS6. 6. Keng, S.-L., Looi, P. S., Tan, E. L. Y., Yim, O.-S., Lai, P. S., Chew, S. H., & Ebstein, R. P. (2020). Effects of Mindfulness-based Stress Reduction on Psychological Symptoms and Telomere Length: A Randomized Active-Controlled Trial. Behavior Therapy. https://doi.org/10.1016/j.beth.2020.01.005 of life of babies of smoking and non-smoking mothers. Early Human Development, 140, 104889.
Year 2018 7. Ebstein, R.P. (2018). Has the gloom lifted on genome-wide association studies? Biol. Psychiatry, 83: In press 8. Krol, K. et al. (2018). Genetic variation in the maternal oxytocin system affects cortisol responsiveness to breastfeeding in infants and mothers. Adaptive Human Behavior and Physiology. In press. 9. Schirmer A, Ng T, Ebstein RP. Vicarious Social Touch Biases Gazing at Faces and Facial Emotions. Emotion. 2018. doi:10.1037/emo0000393 10. Martin J, Walters RK, Demontis D, et al. A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry. 2018;83(12). doi:10.1016/j.biopsych.2017.11.026
Year 2017 11. Chong, A., Malavasi, F., Israel, S., Khor, C. C., Yap, V. B., Monakhov, M., … Ebstein, R. P. (2017). ADP ribosyl-cyclases (CD38/CD157), social skills and friendship. Psychoneuroendocrinology, 78, 185–192. 12. Foo, J. N., Tan, L. C., Irwan, I. D., Au, W.-L., Low, H. Q., Prakash, K.-M., … Tan, E.- K. (2017). Genome-wide association study of Parkinson’s disease in East Asians. Human Molecular Genetics, 26(1), 226–232. https://doi.org/10.1093/hmg/ddw379
Year 2016 13. Naaijen, J., Bralten, J., Poelmans, G., Faraone, S., Asherson, P., Banaschewski, T., … Buitelaar, J. K. (2017). Glutamatergic and GABAergic gene sets in attention- deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism. Translational Psychiatry, 7(1), e999. https://doi.org/10.1038/tp.2016.273 14. Friedlander E, Feldstein O, Mankuta D, Yaari M, Harel-Gadassi A, Ebstein RP, Yirmiya N (2017): Social impairments among children perinatally exposed to oxytocin or oxytocin receptor antagonist. Early Hum Dev. 106–107. doi: 10.1016/j.earlhumdev.2017.01.008. 15. Feldman R, Monakhov M, Pratt M, Ebstein RP. Oxytocin Pathway Genes: Evolutionary Ancient System Impacting on Human Affiliation, Sociality, and Psychopathology. Biol Psychiatry. 2016;79(3). 16. Friedlander E, Mankuta D, Yaari M, Harel A, Ebstein R, Yirmiya N. Cognitive and social-communication abilities among young children conceived by assisted reproductive technologies. Eur J Dev Psychol. 2016;13(5). 17. Gamliel M, Anderson KL, Ebstein RP, Yirmiya N, Mankuta D. The oxytocin-CD38- Vitamin A axis in pregnant women involves both hypothalamic and placental regulation. J Matern Neonatal Med. 2016;29(16). 18. Heled E, Hoofien D, Bachar E, Ebstein RP. Verbal Versus Figural Fluency Tests in Currently Ill and Weight Restored Anorexia Nervosa Patients. Eur Eat Disord Rev. 2016;24(3). 19. Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, et al. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nat Genet. 2016;48(5). 20. Reece C, Ebstein R, Cheng X, Ng T, Schirmer A. Data set demonstrating an absence of touch effects on social orienting in adults. Data Br. 2016;8. 21. Reece C, Ebstein R, Cheng X, Ng T, Schirmer A. Maternal touch predicts social orienting in young children. Cogn Dev. 2016;39.
Year 2015 22. Chen FS, Kumsta R, Dvorak F, Domes G, Yim OS, Ebstein RP, et al. Genetic modulation of oxytocin sensitivity: A pharmacogenetic approach. Transl Psychiatry. 2015;5(10). 23. Heled E, Hoofien D, Bachar E, Gur E, Ebstein RP. Extreme Fragmentation in the Rey- Osterrieth complex figure test: a neuropsychological case study of a patient with anorexia nervosa. Eat Weight Disord. 2015;20(2). 24. Klein M, van der Voet M, Harich B, van Hulzen KJE, Onnink AMH, Hoogman M, et al. Converging evidence does not support GIT1 as an ADHD risk gene. Am J Med Genet Part B Neuropsychiatr Genet. 2015;168(6). 25. Krol KM, Monakhov M, Lai PS, Ebstein RP, Grossmann T. Genetic variation in CD38 and breastfeeding experience interact to impact infants’ attention to social eye cues. Proc Natl Acad Sci U S A. 2015;112(39). 26. Li M, Foo J-N, Wang J-Q, Low H-Q, Tang X-Q, Toh K-Y, et al. Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun. 2015;6. 27. Uzefovsky F, Shalev I, Israel S, Edelman S, Raz Y, Mankuta D, et al. Oxytocin receptor and vasopressin receptor 1a genes are respectively associated with emotional and cognitive empathy. Horm Behav. 2015;67. 28. Weisman O, Pelphrey KA, Leckman JF, Feldman R, Lu Y, Chong A, …Ebstein, RP. The association between 2D:4D ratio and cognitive empathy is contingent on a common polymorphism in the oxytocin receptor gene (OXTR rs53576). Psychoneuroendocrinology. 2015;58.
Year 2014 29. Bachner-Melman R, Ebstein RP. The role of oxytocin and vasopressin in emotional and social behaviors. Vol. 124, Handbook of Clinical Neurology. 2014. 30. Dadds MR, Moul C, Cauchi A, Dobson-Stone C, Hawes DJ, Brennan J, et al. Methylation of the oxytocin receptor gene and oxytocin blood levels in the development of psychopathy. Dev Psychopathol. 2014;26(1). 31. Dadds MR, Moul C, Cauchi A, Dobson-Stone C, Hawes DJ, Brennan J, et al. Polymorphisms in the oxytocin receptor gene are associated with the development of psychopathy. Dev Psychopathol. 2014;26(1). 32. De Dreu CKW, Baas M, Roskes M, Sligte DJ, Ebstein RP, Chew SH, et al. Oxytonergic circuitry sustains and enables creative cognition in humans. Soc Cogn Affect Neurosci. 2014;9(8). 33. Feldman R, Vengrober A, Ebstein RP. Affiliation buffers stress: Cumulative genetic risk in oxytocin-vasopressin genes combines with early caregiving to predict PTSD in war-exposed young children. Transl Psychiatry. 2014;4. 34. Heled E, Hoofien D, Bachar E, Cooper-Kazaz R, Gur E, Ebstein RP. Employing executive functions of perceptual and memory abilities in underweight and weight- restored anorexia nervosa patients. Eat Weight Disord. 2014;19(4). 35. Heled E, Hoofien D, Bachner-Melman R, Bachar E, Ebstein RP. The sorting test of the D-KEFS in current and weight restored anorexia nervosa patients. Int J Eat Disord. 2014;47(1). 36. Schneiderman I, Kanat-Maymon Y, Ebstein RP, Feldman R. Cumulative risk on the oxytocin receptor gene (OXTR) underpins empathic communication difficulties at the first stages of romantic love. Soc Cogn Affect Neurosci. 2014;9(10). 37. Smidts A, Hsu M, Sanfey AG, Boksem MAS, Ebstein RB, Huettel SA, et al. Advancing consumer neuroscience. Mark Lett. 2014;25(3). 38. Smith TF, Anastopoulos AD, Garrett ME, Arias-Vasquez A, Franke B, Oades RD, et al. Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity. Am J Med Genet Part B Neuropsychiatr Genet. 2014;165(8). 39. Uzefovsky F, Shalev I, Israel S, Edelman S, Raz Y, Perach-Barzilay N, et al. The Dopamine D4 receptor gene shows a gender-sensitive association with cognitive empathy: Evidence from two independent samples. Emotion. 2014;14(4).
Year 2013 40. Apter-Levy Y, Feldman M, Vakart A, Ebstein RP, Feldman R. Impact of maternal depression across the first 6 years of life on the child’s mental health, social engagement, and empathy: The moderating role of oxytocin. Am J Psychiatry. 2013;170(10). 41. Bralten J, Franke B, Waldman I, Rommelse N, Hartman C, Asherson P, et al. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2013;52(11). 42. Camperio Ciani AS, Edelman S, Ebstein RP. The Dopamine D4 Receptor (DRD4) Exon 3 VNTR Contributes to Adaptive Personality Differences in an Italian Small Island Population. Eur J Pers. 2013;27(6). 43. Feldman R, Gordon I, Influs M, Gutbir T, Ebstein RP. Parental oxytocin and early caregiving jointly shape children’s oxytocin response and social reciprocity. Neuropsychopharmacology. 2013;38(7). 44. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9). 45. Levin R, Bachner-Melman R, Edelman S, Ebstein RP, Heresco-Levy U, Lichtenberg P. Hypnotizability is associated with a protective but not acquisitive self-presentation style. Int J Clin Exp Hypn. 2013;61(2). 46. Mayseless N, Uzefovsky F, Shalev I, Ebstein RP, Shamay-Tsoory SG. The association between creativity and 7R polymorphism in the dopamine receptor D4 gene (DRD4). Front Hum Neurosci. 2013;(AUG). 47. Mota NR, Bau CHD, Banaschewski T, Buitelaar JK, Ebstein RP, Franke B, et al. Association between DRD2/DRD4 interaction and conduct disorder: A potential developmental pathway to alcohol dependence. Am J Med Genet Part B Neuropsychiatr Genet. 2013;162(6). 48. Pener-Tessler R, Avinun R, Uzefovsky F, Edelman S, Ebstein RP, Knafo A. Boys’ serotonin transporter genotype affects maternal behavior through self-control: A case of evocative gene-environment correlation. Dev Psychopathol. 2013;25(1). 49. Shalev I, Ebstein RP. Frontiers in oxytocin science: From basic to practice. Front Neurosci. 2013;(7 DEC). 50. Tan DEK, Foo JN, Bei J-X, Chang J, Peng R, Zheng X, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet. 2013;45(7). 51. Treister R, Pud D, Ebstein RP, Eisenberg E. Dopamine Transporter Genotype Dependent Effects of Apomorphine on Cold Pain Tolerance in Healthy Volunteers. PLoS One. 2013;8(5).
Year 2012 52. Avinun R, Ebstein RP, Knafo A. Human maternal behaviour is associated with arginine vasopressin receptor 1A gene. Biol Lett. 2012;8(5). 53. Bromberg A, Lerer E, Udawela M, Scarr E, Dean B, Belmaker RH, et al. Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: Genetic association and decreased frontal cortex mRNA levels. Int J Neuropsychopharmacol. 2012;15(6). 54. Ebstein RP, Knafo A, Mankuta D, Chew SH, Lai PS. The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav. 2012;61(3). 55. Edelman S, Shalev I, Uzefovsky F, Israel S, Knafo A, Kremer I, et al. Epigenetic and Genetic Factors Predict Women’s Salivary Cortisol following a Threat to the Social Self. PLoS One. 2012;7(11). 56. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2012;44(1). 57. Feldman R, Zagoory-Sharon O, Weisman O, Schneiderman I, Gordon I, Maoz R, et al. Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes. Biol Psychiatry. 2012;72(3). 58. Fliers EA, Vasquez AA, Poelmans G, Rommelse N, Altink M, Buschgens C, et al. Genome-wide association study of motor coordination problems in ADHD identifies genes for brain and muscle function. World J Biol Psychiatry. 2012;13(3). 59. Gamliel M, Ebstein R, Yirmiya N, Mankuta D. Minor fetal sonographic findings in autism spectrum disorder. Obstet Gynecol Surv. 2012;67(3). 60. Kaitz M, Sabato R, Shalev I, Ebstein R, Mankuta D. Children’s noncompliance during saliva collection predicts measures of salivary cortisol. Dev Psychobiol. 2012;54(2). 61. Lim J, Ebstein R, Tse C-Y, Monakhov M, Lai PS, Dinges DF, et al. Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the psychomotor vigilance test. PLoS One. 2012;7(3). 62. Seidman I, Yirmiya N, Milshtein S, Ebstein RP, Levi S. The broad autism phenotype questionnaire: Mothers versus fathers of children with an autism spectrum disorder. J Autism Dev Disord. 2012;42(5). 63. Stergiakouli E, Hamshere M, Holmans P, Langley K, Zaharieva I, Hawi Z, et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry. 2012;169(2). 64. Toplak ME, Sorge GB, Flora DB, Chen W, Banaschewski T, Buitelaar J, et al. The hierarchical factor model of ADHD: Invariant across age and national groupings? J Child Psychol Psychiatry Allied Discip. 2012;53(3). 65. Treister R, Pud D, Ebstein RP, Laiba E, Raz Y, Gershon E, et al. Reply. J Pain. 2012;13(5). 66. Uzefovsky F, Shalev I, Israel S, Knafo A, Ebstein RP. Vasopressin selectively impairs emotion recognition in men. Psychoneuroendocrinology. 2012;37(4).
Year 2011 67. Ben-David E, Granot-Hershkovitz E, Monderer-Rothkoff G, Lerer E, Levi S, Yaari M, et al. Identification of a functional rare variant in autism using genome-wide screen for monoallelic expression. Hum Mol Genet. 2011;20(18). 68. Chen FS, Kumsta R, Von Dawans B, Monakhov M, Ebstein RP, Heinrichs M. Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proc Natl Acad Sci U S A. 2011;108(50). 69. Ebstein RP, Mankuta D, Yirmiya N, Malavasi F. Are retinoids potential therapeutic agents in disorders of social cognition including autism? FEBS Lett. 2011;585(11). 70. Ebstein RP, Monakhov M, Lai PS, Shamay-Tsoory SG. Introduction. From DNA to Social Cognition. 2011. 71. Ebstein RP, Shalev I, Israel S, Uzefovsky F, Avinun R, Knafo A, et al. Oxytocin and vasopressin in human sociality and social psychopathologies. Oxytocin, Vasopressin, and Related Peptides in the Regulation of Behavior. 2011. 72. Fortuna K, van IJzendoorn MH, Mankuta D, Kaitz M, Avinun R, Ebstein RP, et al. Differential genetic susceptibility to child risk at birth in predicting observed maternal behavior. PLoS One. 2011;6(5). 73. Greenbaum L, Levin R, Lerer E, Alkelai A, Kohn Y, Heresco-Levy U, et al. Association of Reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli population. Biol Psychiatry. 2011;69(5). 74. Knafo A, Israel S, Ebstein RP. Heritability of children’s prosocial behavior and differential susceptibility to parenting by variation in the dopamine receptor D4 gene. Dev Psychopathol. 2011;23(1). 75. Levin R, Bachner-Melman R, Lichtenberg P, Edelman S, Ebstein RP, Heresco-Levy U. Defensive self-presentation style is associated with reduced prepulse inhibition. Eur Neuropsychopharmacol. 2011;21(11). 76. Levin R, Heresco-Levy U, Edelman S, Shapira H, Ebstein RP, Lichtenberg P. Hypnotizability and sensorimotor gating: A dopaminergic mechanism of hypnosis. Int J Clin Exp Hypn. 2011;59(4). 77. Muller UC, Asherson P, Banaschewski T, Buitelaar JK, Ebstein RP, Eisenberg J, et al. The impact of study design and diagnostic approach in a large multi-centre ADHD study: Part 2: Dimensional measures of psychopathology and intelligence. BMC Psychiatry. 2011;11. 78. Muller UC, Asherson P, Banaschewski T, Buitelaar JK, Ebstein RP, Eisenberg J, et al. The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns. BMC Psychiatry. 2011;11. 79. Riebold M, Mankuta D, Lere E, Israel S, Zhong S, Nemanov L, et al. All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder. Mol Med. 2011;17(7–8). 80. Rizzi TS, Arias-Vasquez A, Rommelse N, Kuntsi J, Anney R, Asherson P, et al. The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: Evidence from a large collaborative study totaling 4,963 Subjects. Am J Med Genet Part B Neuropsychiatr Genet. 2011;156(2). 81. Shalev I, Israel S, Uzefovsky F, Gritsenko I, Kaitz M, Ebstein RP. Vasopressin needs an audience: Neuropeptide elicited stress responses are contingent upon perceived social evaluative threats. Horm Behav. 2011;60(1). 82. Sonuga-Barke EJS, Kumsta R, Schlotz W, Lasky-Su J, Marco R, Miranda A, et al. A functional variant of the serotonin transporter gene ((SLC6A4) moderates impulsive choice in attention-deficit/hyperactivity disorder boys and siblings. Biol Psychiatry. 2011;70(3). 83. Treister R, Pud D, Ebstein RP, Laiba E, Raz Y, Gershon E, et al. Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation. J Pain. 2011;12(8). 84. van Ijzendoorn MH, Bakermans-Kranenburg MJ, Ebstein RP. Methylation matters in child development: Toward developmental behavioral epigenetics. Child Dev Perspect. 2011;5(4).
Year 2010 85. Aebi M, Muller UC, Asherson P, Banaschewski T, Buitelaar J, Ebstein R, et al. Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med. 2010;40(12). 86. Amar S, Ovadia O, Maier W, Ebstein R, Belmaker RH, Mishmar D, et al. Copy number variation of the SELENBP1 gene in schizophrenia. Behav Brain Funct. 2010;6. 87. Auerbach JG, Atzaba-Poria N, Berger A, Landau R, Arbelle S, Raz Y, et al. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys. Psychiatr Genet. 2010;20(4). 88. Bloch B, Reshef A, Cohen T, Tafla A, Gathas S, Israel S, et al. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. Psychiatry Res. 2010;175(1–2). 89. Glazer Y, Buskila D, Cohen H, Ebstein RP, Neumann L. Differences in the personality profile of fibromyalgia patients and their relatives with and without fibromyalgia. Clin Exp Rheumatol. 2010;28(6 SUPPL. 63). 90. Golimbet VE, Alfimova MV, Gritsenko IK, Lezheiko TV, Lavrushina OM, Abramova LI, et al. Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects. Neurosci Behav Physiol. 2010;40(4). 91. Hawi Z, Kent L, Hill M, Anney RJL, Brookes KJ, Barry E, et al. ADHD and DAT1: Further evidence of paternal over-transmission of risk alleles and haplotype. Am J Med Genet Part B Neuropsychiatr Genet. 2010;153(1). 92. Kaitz M, Shalev I, Sapir N, Devor N, Samet Y, Mankuta D, et al. Mothers’ dopamine receptor polymorphism modulates the relation between infant fussiness and sensitive parenting. Dev Psychobiol. 2010;52(2). 93. Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, et al. Healthy aging and preclinical dementia: The United States-Israel Longitudinal Database Project. Alzheimer’s Dement. 2010;6(6). 94. Lerer E, Levi S, Israel S, Yaari M, Nemanov L, Mankuta D, et al. Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 2010;3(6). 95. Levin R, Edelman S, Shalev I, Ebstein RP, Heresco-Levy U. The role of oxytocin in neuropsychiatric disorders: Concepts and mechanisms. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. 2010. 96. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch K-P, et al. Meta- analysis of genome-wide association studies of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9). 97. Nijmeijer JS, Arias-Vsquez A, Rommelse NNJ, Altink ME, Anney RJL, Asherson P, et al. Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach. J Am Acad Child Adolesc Psychiatry. 2010;49(7). 98. Perry A, Bentin S, Shalev I, Israel S, Uzefovsky F, Bar-On D, et al. Intranasal oxytocin modulates EEG mu/alpha and beta rhythms during perception of biological motion. Psychoneuroendocrinology. 2010;35(10). 99. Sobanski E, Banaschewski T, Asherson P, Buitelaar J, Chen W, Franke B, et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): Clinical correlates and familial prevalence. J Child Psychol Psychiatry Allied Discip. 2010;51(8). 100. Torri F, Akelai A, Lupoli S, Sironi M, Amann-Zalcenstein D, Fumagalli M, et al. Fine mapping of AHI1 as a schizophrenia susceptibility gene: From association to evolutionary evidence. FASEB J. 2010;24(8).
Year 2009 101. Bachner-Melman R, Bacon-Shnoor N, Zohar AH, Elizur Y, Ebstein RP. The psychometric properties of the revised self-monitoring scale (RSMS) and the concern for appropriateness scale (CAS) in Hebrew. Eur J Psychol Assess. 2009;25(1). 102. Bachner-Melman R, Zohar AH, Elizur Y, Kremer I, Golan M, Ebstein R. Protective self-presentation style: Association with disordered eating and anorexia nervosa mediated by sociocultural attitudes towards appearance. Eat Weight Disord. 2009;14(1). 103. Bachner-Melman R, Zohar AH, Kremer I, Komer M, Blank S, Golan M, et al. Self-monitoring in anorexia nervosa. Int J Soc Psychiatry. 2009;55(2). 104. Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val158met and fibromyalgia. Clin Exp Rheumatol. 2009;27(5 SUPPL. 56). 105. Ebstein RP, Israel S. Molecular genetics of personality: How our genes can bring us to a better understanding of why we act the way we do. Handbook of Behavior Genetics. 2009. 106. Ebstein RP, Israel S, Lerer E, Uzefovsky F, Shalev I, Gritsenko I, et al. Arginine vasopressin and oxytocin modulate human social behavior. Vol. 1167, Annals of the New York Academy of Sciences. 2009. 107. Glazer Y, Cohen H, Buskila D, Ebstein RP, Glotser L, Neumann L. Are psychological distress symptoms different in fibromyalgia patients compared to relatives with and without fibromyalgia? Clin Exp Rheumatol. 2009;27(5 SUPPL. 56). 108. Glazer Y, Cohen H, Buskila D, Ebstein RP, Glotser L, Neumann L. Are psychological distress symptoms different in fibromyalgia patients compared to relatives with and without fibromyalgia? Clin Exp Rheumatol. 2009;27(5 Suppl 56). 109. Goldstein I, Lerer E, Laiba E, Mallet J, Mujaheed M, Laurent C, et al. Association Between Sodium- and Potassium-Activated Adenosine Triphosphatase ? Isoforms and Bipolar Disorders. Biol Psychiatry. 2009;65(11). 110. Goumbet VE, Alfimova MV, Gritsenko IK, Lezheiko TV, Lavrushina OM, Abramova LI, et al. The association of the SNAP-25 gene polymorphism with verbal memory and attention in patients with major psychosis and healthy people. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2009;109(1). 111. Kaitz M, Levy M, Ebstein R, Faraone SV, Mankuta D. The intergenerational effects of trauma from terror: A real possibility. Infant Ment Health J. 2009;30(2). 112. Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology. 2009;34(6). 113. Levy Y, Ebstein RP. Research review: Crossing syndrome boundaries in the search for brain endophenotypes. J Child Psychol Psychiatry Allied Discip. 2009;50(6). 114. Mulligan A, Anney RJL, O’Regan M, Chen W, Butler L, Fitzgerald M, et al. Autism symptoms in attention-deficit/hyperactivity disorder: A familial trait which correlates with conduct, oppositional defiant, language and motor disorders (Journal of Autism and Developmental Disorders DOI: 10.1007/s10803-008-0621-3). J Autism Dev Disord. 2009;39(2). 115. Mulligan A, Anney RJL, O’Regan M, Chen W, Butler L, Fitzgerald M, et al. Autism symptoms in attention-deficit/hyperactivity disorder: A familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J Autism Dev Disord. 2009;39(2). 116. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, et al. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology. 2009;34(3). 117. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, et al. Individual Differences in Reactivity to Social Stress in the Laboratory and Its Mediation by Common Genetic Polymorphisms. Stress - From Molecules to Behavior: A Comprehensive Analysis of the Neurobiology of Stress Responses. 2009. 118. Sonuga-Barke EJS, Oades RD, Psychogiou L, Chen W, Franke B, Buitelaar J, et al. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: The case of conduct and emotional problems in attention deficit/hyperactivity disorder. J Child Psychol Psychiatry Allied Discip. 2009;50(9). 119. Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, et al. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain. 2009;147(1–3). 120. Xu X, Duman EA, Anney R, Brookes K, Franke B, Zhou K, et al. No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder (American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics (2008) 147B, (1306-1309)). Am J Med Genet Part B Neuropsychiatr Genet. 2009;150(1).
Year 2008 121. Anney RJL, Hawi Z, Sheehan K, Mulligan A, Pinto C, Brookes KJ, et al. Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): Analysis of data from the international multicenter ADHD genetics (IMAGE) program. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 122. Anney RJL, Lasky-Su J, ?’D?shl?ine C, Kenny E, Neale BM, Mulligan A, et al. Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 123. Asherson P, Zhou K, Anney RJL, Franke B, Buitelaar J, Ebstein R, et al. A high- density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry. 2008;13(5). 124. Brookes KJ, Neale B, Xu X, Thapar A, Gill M, Langley K, et al. Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(1). 125. Brookes KJ, Xu X, Anney R, Franke B, Zhou K, Chen W, et al. Association of ADHD with genetic variants in the 5?-region of the dopamine transporter gene: Evidence for allelic heterogeneity. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 126. Chen W, Zhou K, Sham P, Franke B, Kuntsi J, Campbell D, et al. DSM-IV combined type ADHD shows familial association with sibling trait scores: A sampling strategy for QTL linkage. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 127. Christiansen H, Chen W, Oades RD, Asherson P, Taylor EA, Lasky-Su J, et al. Co- transmission of conduct problems with attention-deficit/hyperactivity disorder: Familial evidence for a distinct disorder. J Neural Transm. 2008;115(2). 128. Golimbet VE, Alfimova MV, Gritsenko IK, Lezheiko TV, Ebstein R. Association of dopamine receptor D5 gene polymorphism with peculiarities of voluntary attention in schizophrenic patients and their relatives. Bull Exp Biol Med. 2008;145(1). 129. Lasky-Su J, Anney RJL, Neale BM, Franke B, Zhou K, Maller JB, et al. Genome- wide association scan of the time to onset of attention deficit hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 130. Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, Maller JB, et al. Genome- wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 131. Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP. Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Mol Psychiatry. 2008;13(10). 132. Manor I, Laiba E, Eisenberg J, Meidad S, Lerer E, Israel S, et al. Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 133. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, et al. Genome- wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 134. Neale BM, Sham PC, Purcell S, Banaschewski T, Buitelaar J, Franke B, et al. Population differences in the International Multi-Centre ADHD Gene (IMAGE) project (Genetic Epidemiology DOI: 10.1002/gepi.20265). Genet Epidemiol. 2008;32(2). 135. Neale BM, Sham PC, Purcell S, Banaschewski T, Buitelaar J, Franke B, et al. Population differences in the international multi-centre ADHD gene project. Genet Epidemiol. 2008;32(2). 136. Oades RD, Lasky-Su J, Christiansen H, Faraone SV, Sonuga-Barke EJS, Banaschewski T, et al. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct. 2008;4.
137. Sonuga-Barke EJS, Brookes K-J, Buitelaar J, Anney R, Bitsakou P, Baeyens D, et al. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(3). 138. Sonuga-Barke EJS, Brookes K-J, Buitelaar J, Anney R, Bitsakou P, Baeyens D, et al. Erratum: Intelligence in DSM-IV combined type attention-deficit/ hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/ hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(5). 139. Sonuga-Barke EJS, Lasky-Su J, Neale BM, Oades R, Chen W, Franke B, et al. Does parental expressed emotion moderate genetic effects in ADHD? An exploration using a genome wide association scan. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 140. Xu X, Aysimi E, Anney R, Brookes K, Franke B, Zhou K, et al. No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(7). 141. Xu X, Hawi Z, Brookes KJ, Anney R, Bellgrove M, Franke B, et al. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 142. Zhou K, Asherson P, Sham P, Franke B, Anney RJL, Buitelaar J, et al. Linkage to Chromosome 1p36 for Attention-Deficit/Hyperactivity Disorder Traits in School and Home Settings. Biol Psychiatry. 2008;64(7). 143. Zhou K, Chen W, Buitelaar J, Banaschewski T, Oades RD, Franke B, et al. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8). 144. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147(8).
Year 2007 145. Alfimova MV, Golimbet VE, Gritsenko IK, Lezheiko TV, Abramova LI, Strel’tsova MA, et al. Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population. Neurosci Behav Physiol. 2007;37(7). 146. Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. Erratum: AHI1, a pivotal neurodevelopment gene, and C6orf217 are associated with susceptibility to schizophrenia (European Journal of Human Genetics (2006) vol. 14 (1111-1119) 10.1038/sj.ejhg.5201675). Eur J Hum Genet. 2007;15(3). 147. Amar S, Shamir A, Ovadia O, Blanaru M, Reshef A, Kremer I, et al. Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs. Schizophr Res. 2007;94(1–3). 148. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, et al. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined- type ADHD. Am J Psychiatry. 2007;164(4). 149. Bachner-Melman R, Lerer E, Zohar AH, Kremer I, Elizur Y, Nemanov L, et al. Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). Am J Med Genet Part B Neuropsychiatr Genet. 2007;144(6). 150. Bachner-Melman R, Zohar AH, Ebstein RP, Bachar E. The relationship between selflessness levels and the severity of anorexia nervosa symptomatology. Eur Eat Disord Rev. 2007;15(3). 151. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP. Relationship between dopamine system genes and extraversion and novelty seeking. Neurosci Behav Physiol. 2007;37(6). 152. Granot RY, Frankel Y, Gritsenko V, Lerer E, Gritsenko I, Bachner-Melman R, et al. Provisional evidence that the arginine vasopressin 1a receptor gene is associated with musical memory. Evol Hum Behav. 2007;28(5).
153. Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC. High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007;91(1–3) 154. Lasky-Su J, Banaschewski T, Buitelaar J, Franke B, Brookes K, Sonuga-Barke E, et al. Partial Replication of a DRD4 Association in ADHD Individuals Using a Statistically Derived Quantitative Trait for ADHD in a Family-Based Association Test. Biol Psychiatry. 2007;62(9).
Year 2006 155. Alfimova MV, Golimbet VE, Gritsenko IK, Lezheiko TV, Abramova LI, Streltsova MA, et al. Dopamine system genes interaction and neurocognitive traits in patients with schizophrenia, their relatives and healthy controls from general population. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2006;106(7). 156. Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet. 2006;14(10). 157. Bachner-Melman R, Zohar AH, Ebstein RP. An examination of cognitive versus behavioral components of recovery from anorexia nervosa. J Nerv Ment Dis. 2006;194(9). 158. Bachner-Melman R, Zohar AH, Ebstein RP, Elizur Y, Constantini N. How anorexic-like are the symptom and personality profiles of aesthetic athletes? Med Sci Sports Exerc. 2006;38(4). 159. Ben Zion IZ, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, et al. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: Desire, arousal and sexual function. Mol Psychiatry. 2006;11(8). 160. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11(10). 161. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. Erratum: The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes (Molecular Psychiatry (2006) 11, (934-953) DOI: 10.1038/sj.mp.4001869). Mol Psychiatry. 2006;11(12). 162. Ebstein RP. The molecular genetic architecture of human personality: Beyond self- report questionnaires. Mol Psychiatry. 2006;11(5). 163. Golimbet V, Gritsenko I, Alfimova M, Lebedeva I, Lezheiko T, Abramova L, et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry. 2006;7(4). 164. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP. Dopamine system genes and personality traits of extraversion and novelty seeking. Zhurnal Vyss Nervn Deyatelnosti Im IP Pavlov. 2006;56(4). 165. Ivo R, Schulze TG, Schumacher J, Kesper K, M?ller DJ, Kremer I, et al. No evidence for association between NOTCH4 and schizophrenia in a large family-based and case-control association analysis. Psychiatr Genet. 2006;16(5). 166. Korobochka R, Gritsenko I, Gonen R, Ebstein RP, Ohel G. Association between a functional dopamine D4 receptor promoter region polymorphism (-C521T) and pre- eclampsia: A family-based study. Mol Hum Reprod. 2006;12(2). 167. Korostishevsky M, Kremer I, Kaganovich M, Cholostoy A, Murad I, Muhaheed M, et al. Transmission disequilibrium and haplotype analyses of the G72/G30 locus: Suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel. Am J Med Genet - Neuropsychiatr Genet. 2006;141 B(1). 168. Lerer E, Kanyas K, Karni O, Ebstein RP, Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry. 2006;11(8). 169. Yirmiya N, Rosenberg C, Levi S, Salomon S, Shulman C, Nemanov L, et al. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: Mediation by socialization skills. Mol Psychiatry. 2006;11(5).
Year 2005 170. Bachner-Melman R, Dina C, Zohar AH, Constantini N, Lerer E, Hoch S, et al. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet. 2005;1(3). 171. Bachner-Melman R, Dina C, Zohar AH, Constantini N, Lerer E, Hoch S, et al. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet. 2005;1(3). 172. Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Dina C, Ebstein RP. Dopaminergic polymorphisms associated with self-report measures of human altruism: A fresh phenotype for the dopamine D4 receptor [3]. Mol Psychiatry. 2005;10(4). 173. Bachner-Melman R, Zohar AH, Nemanov L, Heresco-Levy U, Gritsenko I, Ebstein RP. Association between the insulin-like growth factor 2 gene (IGF2) and scores on the eating attitudes test in nonclinical subjects: A family-based study. Am J Psychiatry. 2005;162(12). 174. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein RP, Marcus E-L, et al. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson’s disease. FASEB J. 2005;19(3). 175. Dina C, Nemanov L, Gritsenko I, Rosolio N, Osher Y, Heresco-Levy U, et al. Fine mapping of a region on chromosome 8p gives evidence for a QTL contributing to individual differences in an anxiety-related personality trait: TPQ harm avoidance. Am J Med Genet - Neuropsychiatr Genet. 2005;132 B(1). 176. Golimbet VE, Gritsenko IK, Alfimova MV, Ebstein RP. Polymorphic markers of the dopamine D4 receptor gene promoter region and personality traits in mentally healthy individuals from the Russian population. Russ J Genet. 2005;41(7). 177. Golimbet VE, Gritsenko IK, Alfimova MV, Ebstein RP. Polymorphic markers of the dopamine D4 receptor gene promoter region and personality traits in mentally healthy individuals from the Russian population. Genetika. 2005;41(7). 178. Golimbet VE, Gritsenko IK, Alfimova MV, Lezheiko TV, Abramova LI, Barkhatova AN, et al. Dopamine receptor DRD4 gene polymorphism and its association with schizophrenia spectrum disorders and personality traits of patients. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2005;105(9). 179. Golimbet VE, Lebedeva IS, Gritsenko IK, Korovaitseva GI, Alfimova MV, Lezheiko TV, et al. A study of some genes related to serotoninergic and dopaminergic systems and auditory evoked-potentials (P300) in patients with schizophrenia and spectrum disorders and their first-degree relatives. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2005;105(10). 180. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, et al. D- serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment- refractory schizophrenia. Biol Psychiatry. 2005;57(6). 181. Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I, et al. Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry. 2005;162(5). 182. Stessman J, Maaravi Y, Hammerman-Rozenberg R, Cohen A, Nemanov L, Gritsenko I, et al. Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. Mech Ageing Dev. 2005;126(2).
Year 2004 183. Bachner-Melman R, Zohar AH, Elizur Y, Nemanov L, Gritsenko I, Konis D, et al. Association between a vasopressin receptor AVPR1A promoter region microsatellite and eating behavior measured by a self-report questionnaire (eating attitudes test) in a family- based study of a nonclinical population. Int J Eat Disord. 2004;36(4). 184. Bah J, Quach H, Ebstein RP, Segman RH, Melke J, Jamain S, et al. Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport. 2004;15(12). 185. Buskila D, Cohen H, Neuman L, Ebstein RP. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry. 2004;9(8). 186. Buskila D, Cohen H, Neumann L, Ebstein RP. Erratum: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits (Molecular Psychiatry (2004) 9 (730- 731) doi:10.1038/mp.4001506). Mol Psychiatry. 2004;9(11). 187. Buskila D, Cohen H, Neumann L, Ebstein RP. Erratum: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits (Molecular Psychiatry (2004) 9 (730- 731) doi:10.1038/mp.4001506). Mol Psychiatry. 2004;9(10). 188. Lichtenberg P, Bachner-Melman R, Ebstein RP, Crawford HJ. Hypnotic susceptibility: Multidimensional relationships with Cloninger’s Tridimensional Personality Questionnaire, COMT polymorphisms, absorption, and attentional characteristics. Int J Clin Exp Hypn. 2004;52(1). 189. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, et al. Joint Analysis of the DRD5 Marker Concludes Association with Attention- Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes. Am J Hum Genet. 2004;74(2). 190. Sj?holt G, Ebstein RP, Lie RT, Berle J?., Mallet J, Deleuze JF, et al. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: Association between IMPA2 promoter polymorphisms and bipolar disorder. Mol Psychiatry. 2004;9(6).
Year 2003 191. Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am J Psychiatry. 2003;160(4). 192. Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, et al. Family- based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet - Neuropsychiatr Genet. 2003;119 B(1). 193. Manor I, Ebstein RP, Weizman A, Tyano S. Efficacy of single low-dose methylphenidate administration in adult ADHD patients according to psychometric assessment | Die wirksamkeit niedrigdosierter einzelgabe von methylphenidat bei erwachsenen ADHD-patienten. Dynamische Psychiatr. 2003;36(1–2). 194. Zohar AH, Dina C, Rosolio N, Osher Y, Gritsenko I, Bachner-Melman R, et al. Tridimensional personality questionnaire trait of harm avoidance (anxiety proneness) is linked to a locus on chromosome 8p21. Am J Med Genet - Neuropsychiatr Genet. 2003;117 B(1).
Year 2002 195. Alsobrook II JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet Part B Neuropsychiatr Genet. 2002;114(1). 196. Bachner-Melman R, Ebstein R, Lichtenberg P. No link between hypnotizability and the self-monitoring scale. Am J Clin Hypn. 2002;45(1). 197. Belmaker RH, Shapiro J, Vainer E, Nemanov L, Ebstein RP, Agam G. Reduced inositol content in lymphocyte-derived cell lines from bipolar patients. Bipolar Disord. 2002;4(1). 198. Benjamin J, Ebstein RP, Belmaker RH. Personality genetics, 2002. Isr J Psychiatry Relat Sci. 2002;39(4). 199. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits [5]. Arthritis Rheum. 2002;46(3). 200. Ebstein RP, Zohar AH, Benjamin J, Belmaker RH. An update on molecular genetic studies of human personality traits. Appl Bioinforma. 2002;1(2). 201. Kluger AN, Siegfried Z, Ebstein RP. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol Psychiatry. 2002;7(7). 202. Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family- based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry. 2002;7(7).
203. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (T. Mol Psychiatry. 2002;7(6). 204. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. Brief research communication: Family-based and population study of a functional promoter- region monoamine oxidase A polymorphism in autism: Possible association with IQ. Am J Med Genet - Neuropsychiatr Genet. 2002;114(3).
Year 2001 205. Auerbach JG, Benjamin J, Faroy M, Geller V, Ebstein R. DRD4 related to infant attention and information processing: A developmental link to ADHD? Psychiatr Genet. 2001;11(1). 206. Auerbach JG, Faroy M, Ebstein R, Kahana M, Levine J. The association of the dopamine D4 receptor gene (DRD4) and the serotonin transporter promoter gene (5- HTTLPR) with temperament in 12-month-old infants. J Child Psychol Psychiatry Allied Discip. 2001;42(6). 207. Benjamin J, Ebstein RP, Belmaker RH. Genes for human personality traits: “Endophenotypes” of psychiatric disorders? World J Biol Psychiatry. 2001;2(2). 208. Cichon S, Schumacher J, Ivo R, Macchiardi F, Schulze TG, M?ller DJ, et al. The NOTCH4 locus and schizophrenia: Analyses in the german and palestinian Arab population. Am J Med Genet - Neuropsychiatr Genet. 2001;105(7). 209. Dobrusin M, Corbex M, Kremer I, Murad I, Muhaheed M, Bannoura I, et al. No evidence for linkage by transmission disequilibrium test analysis of microsatellite marker D22S278 and schizophrenia in a Palestinian Arab and in a German population. Am J Med Genet - Neuropsychiatr Genet. 2001;105(4). 210. Ebstein RP, Buskila D, Cohen H, Neumann L. An association between FMS and the serotonin transporter promoter region (5-HTTLPR) polymorphism and relationship to anxiety-related personality traits. Am J Med Genet - Neuropsychiatr Genet. 2001;105(7). 211. Ebstein RP, Corbex M, Kremer I, Dobrusin M, Murad I, Rietschel M, et al. No evidence for linkage by transmission disequilibrium test analysis of microsatellite markers in chromosomal 1q21-22 REGION to schizophrenia in a palestinian arab population. Am J Med Genet - Neuropsychiatr Genet. 2001;105(7). 212. Ebstein RP, Zohar A, Benjamin J, Osher Y, Bachner-Melman R, Belmaker RH, et al. Linkage study of tridimensional personality questionnaire (TPQ) traits in normal sib pairs to selected chromosomal regions. Am J Med Genet - Neuropsychiatr Genet. 2001;105(7). 213. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, et al. Linkage studies suggest a possible locus for developmental dyslexia on chromosome 1p. Am J Med Genet - Neuropsychiatr Genet. 2001;105(1). 214. Murad I, Kremer I, Dobrusin M, Muhaheed M, Bannoura I, Mller DJ, et al. A family-based study of the Cys23Ser 5HT2C serotonin receptor polymorphism in schizophrenia. Am J Med Genet - Neuropsychiatr Genet. 2001;105(3). 215. Shaltiel G, Shamir A, Nemanov L, Yaroslavsky Y, Nemets B, Ebstein RP, et al. Inositol monophosphatase activity in brain and lymphocyte-derived ceii lines of bipolar patients. World J Biol Psychiatry. 2001;2(2). 216. Shamir A, Sj?holt G, Ebstein RP, Agam G, Steen VM. Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases. Gene. 2001;271(2). 217. Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I, et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet - Neuropsychiatr Genet. 2001;105(4). 218. Zohar AH, Lev-Ari L, Benjamin J, Ebstein R, Lichtenberg P, Osher Y. The psychometric properties of the Hebrew version of Cloninger’s Tridimensional Personality Questionnaire. Pers Individ Dif. 2001;30(8).
Year 2000 219. Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, et al. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: Dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry. 2000;5(1). 220. Benjamin J, Osher Y, Lichtenberg P, Bachner-Melman R, Gritsenko I, Kotler M, et al. An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects. Neuropsychobiology. 2000;41(1). 221. Ebstein RP, Benjamin J, Belmaker RH. Genetics of personality dimensions. Curr Opin Psychiatry. 2000;13(6). 222. Ebstein RP, Benjamin J, Belmaker RH. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol. 2000;410(2–3). 223. Ebstein RP, Horn-Saban S, Nemanov L, Shamir A, Belmaker RH, Agam G. Differential gene expression profiles due to lithium and bipolar disorder. Am J Med Genet - Neuropsychiatr Genet. 2000;96(4). 224. Ebstein RP, Manor I, Eisenberg J, Tyano S, Kotler M, Cohen H. Family-based candidate gene association studies in ADHD. Am J Med Genet - Neuropsychiatr Genet. 2000;96(4). 225. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. Erratum: Haplotype relative risk study of catechol-o-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype (American Journal of Medical Ge. Am J Med Genet - Neuropsychiatr Genet. 2000;96(6). 226. Eisenberg J, Zohar A, Mei-Tal G, Steinberg A, Tartakovsky E, Gritsenko I, et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet - Neuropsychiatr Genet. 2000;96(3). 227. Horowitz R, Kotler M, Shufman E, Aharoni S, Kremer I, Cohen H, et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet - Neuropsychiatr Genet. 2000;96(5). 228. Kotler M, Manor I, Sever Y, Eisenberg J, Cohen H, Ebstein RP, et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet - Neuropsychiatr Genet. 2000;96(3). 229. Kremer I, Rietschel M, Dobrusin M, Mujaheed M, Murad I, Blanaru M, et al. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a palestinian Arab population. Am J Med Genet - Neuropsychiatr Genet. 2000;96(6). 230. Lichtenberg P, Bachner-Melman R, Gritsenko I, Ebstein RP. Exploratory association study between catechol-O-methyltransferase (COMT) high/low enzyme activity polymorphism and hypnotizability. Am J Med Genet - Neuropsychiatr Genet. 2000;96(6). 231. Manor I, Ebstein R. Hereditary basis of attention deficit and hyperactivity disorder. Harefuah. 2000;139(9–10). 232. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, et al. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet - Neuropsychiatr Genet. 2000;96(6). 233. Mujahed M, Corbex M, Lichtenberg P, Levinson DF, Deleuze JF, Mallet J, et al. TDT analysis of D22S278 & bipolar disorder in a Palestinian Arab population. Am J Med Genet - Neuropsychiatr Genet. 2000;96(4). 234. Mujaheed M, Corbex M, Lichtenberg P, Levinson DF, Deleuze J-F, Mallet J, et al. Evidence for linkage by transmission disequilibrium test analysis of a chromosome 22 microsatellite marker D22S278 and bipolar disorder in a Palestinian Arab population. Am J Med Genet - Neuropsychiatr Genet. 2000;96(6).
235. Murad I, Bannoura I, Corbex M, Dobrusin M, Belmaker RH, Kremer I, et al. TDT analysis of D22S278 & schizophrenia in a palestinian Arab population. Am J Med Genet - Neuropsychiatr Genet. 2000;96(4). 236. Shapira M, Tur-Kaspa I, Bosgraaf L, Livni N, Grant AD, Grisaru D, et al. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum Mol Genet. 2000;9(9).
Year 1999 237. Auerbach J, Geller V, Lezer S, Shinwell E, Belmaker RH, Levine J, et al. Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants. Mol Psychiatry. 1999;4(4). 238. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high- enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet - Neuropsychiatr Genet. 1999;88(5). 239. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet - Neuropsychiatr Genet. 1999;88(6). 240. Kotler M, Cohen H, Kremer I, Mel H, Horowitz R, Ohel N, et al. No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction [1]. Mol Psychiatry. 1999;4(4). 241. Nemanov L, Ebstein RP, Belmaker RH, Osher Y, Agam G. Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels. Int J Neuropsychopharmacol. 1999;2(1).
Year 1998 242. Benjamin J, Ebstein RP, Lesch K-P. Genes for personality traits: Implications for psychopathology. Int J Neuropsychopharmacol. 1998;1(2). 243. Benjamin J, Osher Y, Belmaker RH, Ebstein R. No significant associations between two dopamine receptor polymorphisms and normal temperament. Hum Psychopharmacol. 1998;13(1). 244. Ebstein RP, Auerbach J, Getter V, Belmaker RH, Levine J, Letzer S, et al. Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants. Am J Med Genet - Neuropsychiatr Genet. 1998;81(6). 245. Ebstein RP, Levine J, Geller V, Auerbach J, Gritsenko I, Belmaker RH. Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry. 1998;3(3). 246. Gritsenko I, Kotler M, Cohen H, Averbuch IE, Grinshpoon A, Ebstein RP. Aggressive, violent, and dangerous behavior associated with a polymorphism determining high and low catechol O-methyltransferase (COMT) activity. Am J Med Genet - Neuropsychiatr Genet. 1998;81(6). 247. Mel H, Horowitz R, Ohel N, Kramer I, Kotler M, Cohen H, et al. Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III seven- repeat allele and substance abuse in opioid dependent subjects: Relationship of treatment retention to genotype and personality. Addict Biol. 1998;3(4). 248. Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy [2]. Mol Psychiatry. 1998;3(6).
Year 1997 249. Benjamin J, Ebstein RP, Belmaker RH. Personality Genetics. Isr J Psychiatry Relat Sci. 1997;34(4). 250. Ebstein RP. 5-HT(2C) (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: Interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet - Neuropsychiatr Genet. 1997;74(1). 251. Ebstein RP, Belmaker RH. Saga of an adventure gene: Novelty seeking, substance abuse and the dopamine D4 receptor (D4DR) exon III repeat polymorphism. Mol Psychiatry. 1997;2(5). 252. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry. 1997;2(3). 253. Ebstein RP, Macciardi F, Heresco-Levi U, Serretti A, Blaine D, Verga M, et al. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum Hered. 1997;47(1). 254. Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH. Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty Seeking. Mol Psychiatry. 1997;2(5). 255. Kohn Y, Ebstein RP, Heresco-Levy U, Shapira B, Nemanov L, Gritsenko I, et al. Dopamine D4 receptor gene polymorphisms: Relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur Neuropsychopharmacol. 1997;7(1). 256. Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, et al. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry. 1997;2(3). 257. Segman RH, Ebstein RP, Heresco-Levy U, Gorfine M, Avnon M, Gur E, et al. Schizophrenia, chronic hospitalization and the 5-HT(2C) receptor gene. Psychiatr Genet. 1997;7(2). 258. Shoham S, Ebstein RP. The distribution of ?-amyloid precursor protein in rat cortex after systemic kainate-induced seizures. Exp Neurol. 1997;147(2).
Year 1996 259. Ebstein RP, Nemanov L, Lubarski G, Dano M, Trevis T, Korczyn AD. Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer’s disease. Mol Brain Res. 1996;35(1–2). 260. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 1996;12(1). 261. Hammerman-Rozenberg R, Cohen A, Ginsberg G, Maaravi Y, Ebstein RP, Stessman J. Laboratory reference values for the 70 year olds. Isr J Med Sci. 1996;32(8). 262. Wildenauer DB, Hallmayer J, Schwab SG, Albus M, Eckstein GN, Zill P, et al. Searching for susceptibility genes in schizophrenia by genetic linkage analysis. Vol. 61, Cold Spring Harbor Symposia on Quantitative Biology. 1996.
Year 1995 and before 263. Mulcrone J, Whatley SA, Marchbanks R, Wildenauer D, Altmark D, Daoud H, et al. Genetic linkage analysis of schizophrenia using chromosome 11q13-24 markers in Israeli pedigrees. Am J Med Genet - Neuropsychiatr Genet. 1995;60(2). 264. Schwab SG, Albus M, Hallmayer J, H?nig S, Borrmann M, Lichtermann D, et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib?pair linkage analysis. Nat Genet. 1995;11(3). 265. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, et al. Potential linkage for schizophrenia on chromosome 22q12-q13: A replication study. Am J Med Genet - Neuropsychiatr Genet. 1995;60(5). 266. Ebstein RP, Bennett ER, Shoham S, Sokoloff M. Lithium regulation of G protein mRNA levels in PC12 and GH3 cells: theoretical implications for gene therapy in bipolar illness. Gene Ther. 1994;1 Suppl 1. 267. Wertheimer E, Litvin Y, Ebstein RP, Bennet ER, Barbetti F, Accili D, et al. Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. J Clin Endocrinol Metab. 1994;78(5). 268. Ebstein RP, Bennett ER, Sokoloff M, Shoham S. The effect of nerve growth factor on cholinergic cells in primary fetal striatal cultures: characterization by in situ hybridization. Dev Brain Res. 1993;73(2). 269. Kuritzky A, Bennet E, Hering R, Ebstein R. Reduced Sensitivity of Lymphocyte Beta?Adrenergic Receptors in Migraine. Headache J Head Face Pain. 1993;33(4). 270. Ebstein RP. Response. Biol Psychiatry. 1992;31(2). 271. Shoham S, Wertman E, Ebstein RP. Iron accumulation in the rat basal ganglia after excitatory amino acid injections-Dissociation from neuronal loss. Exp Neurol. 1992;118(2). 272. Bennett ER, Yedgar S, Lerer B, Ebstein RP. Phospholipase A
BOOK CHAPTERS 1. Goldstein M, Freedman LS, Ebstein RP, Park DH. Studies on dopamine-beta hydroxylase in mental disorders. pp. 205-10. In: Matthysse SW, Kety SS, ed. Catecholamines and schizophrenia. Oxford, Pergamon Press; 1975. 2. Belmaker RH, Ebstein RP. The search for genetic polymorphisms of human biogenic-amine related enzymes. pp. 241-60. In: Gershon ES et al. (ed), The impact of biology on modern psychiatry. New York, Plenum Press; 1977. 3. Ebstein RP, Belmaker RH. A comparison of the effect of lithium and haloperidol on human peripheral beta-adrenergic adenylate cyclase; pp. 27-39. In: Gershon ES et al., (ed), The impact of biology on modern psychiatry. New York, Plenum Press; 1977. 4. Belmaker RH and Ebstein RP. Adenylate cyclase and the mechanism of lithium action; pp.173- 184. In: "Neuropsychopharmacology", Saletu B (ed), Oxford, Pergamon Press; 1979. 5. Belmaker RH and Ebstein RP. Biochemical genetics and platelet MAO; pp.95-101. In: "Neuropsychopharmacology", Saletu B (ed), Oxford, Pergamon Press; 1979. 6. Ebstein RP and Belmaker RH. Lithium and brain adenylate cyclase; pp. 703-729. In: "Lithium Controversies and Unresolved Issues", Cooper TB, Gershon S, Kline NS and Schou M (eds), Amsterdam, Excerpta Medica; 1979. 7. Bannet J, Belmaker RH and Ebstein RP. Clinical implications of the molecular model of tardive dyskinesia; pp.155-162. In: "Neurotransmitters and Their Receptors", Littauer UZ et al. (eds), New York, John Wiley; 1980. 8. Belmaker RH, Dasberg H and Ebstein RP. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?; pp. 109-118. In: "Endogenous Peptides and Centrally Acting Drugs", Prog. Biochem. Pharmacol. Vol. 16, Levy A et al. (eds), Basel, S. Karger; 1980. 9. Belmaker RH, Lerer B, Ebstein RP and Dasberg H. The adrenergic receptor as the locus of antidepressant therapy in humans; pp. 139-147. In: "Neurotransmitters and Their Receptors", Littauer UA et al. (eds), New York, John Wiley; 1980. 10. Belmaker RH, Zohar J, Ebstein RP. Cyclic nucleotides in mental disorder; pp.187-197. In: Advances in Cyclic Nucleotide Research, vol 12, Hamet P and Sands H (eds), New York, Raven Press; 1980. 11. Ebstein RP, Eliashar S and Belmaker RH. The effect of chronic lithium on adenylate cyclase and dopamine mediated animal behaviors; pp. 395-409. In: "Neurotransmitters and Mental Diseases", Youdim MBH and Usdin E (eds), New York, John Wiley; 1980. 12. Lerer, B, Ebstein RP and Belmaker RH. Receptor mechanisms of lithium action in affective disorders; pp. 131-147. In: Neurotransmitters and their receptors, Littauer UZ et al. (eds), New York: John Wiley; 1980. 13. Belmaker RH, Lerer B and Ebstein RP. Noradrenaline, dopamine and Mood; pp.17-29. In: "Advances in the Biosciences", Vol. 31, "Recent Advances in Neuropsychopharmacology", Angrist B, Burrows GD, Lader M, Lingjaerde O, Sedvall G and Wheatley D (eds), Oxford, Pergamon; 1981. 14. Eisenberg J, BrecherFride E, Weizman R, Ebstein RP and Belmaker RH. Lithium and receptors in an animal model of MBD; pp.1010-1018. In: "Developments in Psychiatry", Vol. 5, Biological Psychiatry, Perris C, Struwe G and Jansson B (eds), Amsterdam, Elsevier; 1981. 15. Ebstein RP, Lerer B, Shlaufman M and Belmaker RH. The effect of repeated electroconvulsive shock treatment on the release of norepinephrine from rat cortical vesicular preparations; pp. 62-66. In: "ECT: Basic Mechanisms", Lerer B, Weiner R and Belmaker RH (eds), London, John Libbey; 1984. 16. Ebstein RP, Nemanov L, Lubarski G, Dano M, Trevis T, Korczyn AD. Lympho-cyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease; pp.91-95. In: G Fiskum (ed) Neurodegenerative Diseases. New York, Plenum Press; 1996. 17. Ebstein RP, Kotler M. Dopamine D4 receptor, personality and substance abuse; pp. 75-92. In: CL Bolis, J Licinio (eds), Genes,Behavior and Health. Geneva: World Health Organization; 1999. 18. Nemanov L, Ebstein RP, Shamir A, Atack JR, Belmaker RH, Agam G. Effect of affective disorders and lithium treatment on inositol monophosphatase transcription and translation. In: Birch NJ, Gallichio V, Becker R, editors. Lithium: 50 Years of Psychopharmacology: Academic Consultancy Services; 1999. 19. Shamir A, Nemanov L, Ebstein RP, Agam G. The lithium-inhibitable enzyme – inositol monophosphatase in bipolar disorder: transcription and translation; pp. 33-43. In: Lucas KC, Becker RW, Gallichio VS (eds), Lithium - 50 Years: Recent Advances in Biology and Medicine. Chesire, Weidner Publishing; 1999. 20. Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I, Ebstein, RP. Analysis of Three Coding Region (Dopamine D4 Receptor, Catechol-O-Methyltransferase & Serotonin Transporter Promoter Region) Polymorphisms in Autism: Evidence for an Association with the Serotonin Transporter. In: Schopler E, Marcus L, Shulman C, Yirmiya N, editors. The Reseach Basis of Autism Intervention: Kluwer Academic/Plenum Press.; 2000. p. 91-101 21. Ebstein RP, Auerbach JG. Dopamine D4 Receptor and Serotonin Transporter Promoter Polymorphisms and Temperament in Early Childhood. In: Benjamin J, Ebstein RP, Belmaker R, H., editors. Molecular Genetics and the Human Personality. First ed. Washington,D.C.: American Psychiatric Publishing, Inc.; 2002. p. 137-149. 22. Ebstein RP, Kotler M. Personality, Substance Abuse, and Genes. In: Benjamin J, Ebstein RP, Belmaker R, H., editors. Molecular Genetics and the Human Personality. First ed. Washington, D.C.: American Psychiatric Publishing, Inc.; 2002. p. 151-163. 23. Benjamin J, Ebstein RP, Belmaker R, H. Genes for Human Personality Traits:Endophenotypes of Psychiatric Disorders. In: Benjamin J, Ebstein RP, Belmaker R, H., editors. Molecular Genetics and the Human Personality. First ed. Washington, D.C.: American Psychiatric Publications, Inc.; 2002. p. 333-344. 24. Ebstein RP, Benjamin J, Belmaker RH. Personality. In: Plomin R, DeFries, JC, Craig IC and McGuffin P (eds), Behavioral Genetics in a Postgenomics world. Washington, DC: APA Books; 2002. ISBN 1-55798-926-5. 25. Ebstein RP, Belmaker R, H. Genetics of sensation or novelty seeking and criminal behavior. In: Glicksohn J, editor. The Neurobiology of Criminal Behavior. Norwell, MA: Kluwer Academic Publishers; 2002. p. 51-77. 26. Ebstein RP, Bachner-Melman, R, Israel, S, Nemanov, L & Gritsenko, I. The human genome project and personality: What we can learn about our inner and outerselves through our genes. In: Robins RW, Fraley CR & Krueger RF, editors. Handbook of Research Methods in Personality Psychology. Guildford Press NY. 2007. P 389-404. 27. Ebstein RP & Salomon I. Molecular Genetics of Personality: How our genes can bring us to a better understanding of why we act the way we do. In Kim YK editor. Handbook of behavioral genetics. Springer NY . 2008. P (in press). 28. Edelman S, Israel S, Ebstein RP. (2009). Glutamate and neuropsychiatric disorders: genetic findings and strategies. In: Heresco-Levy U, Javitt DC (Eds.), Glutamate in neuropsychiatric disorders. Research Signpost, Kerala, India
BOOKS EDITED From DNA to Social Cognition, Richard Ebstein (Editor), Simone Shamay-Tsoory (Editor), Soo Hong Chew (Editor) ISBN: 978-0-470-54396-2, 272 pages. September 2011, Wiley- Blackwell Benjamin J, Ebstein RP, Belmaker R, H. Molecular Genetics and the Human Personality. First ed. Washington, D.C.: American Psychiatric Publishing, Inc.; 2002.
EDITORIAL BOARD Molecular Psychiatry Letters on Evolutionary Behavioral Science Journal of Individual Differences Current Psychopharmacology Review Editorial Board of Frontiers in Cognitive Science, a specialty of Frontiers in Psychology. Culture and the Brain Messenger Cogent Medicine. Journal of Childhood & Development Disorders
MEMBERSHIPS Israel Society for Biological Psychiatry – (past Board of Directors) International Society for Psychiatric Genetics American Association for the Advancement of Science
AWARDS FASS Certificate for Excellence in Research in 2013 (FASS top 20% Researchers) National University of Singapore “ODPRT Grant for Research Excellence” 2013 Hebrew University-Hadassah Medical School Faculty Research Prize for study entitled "Lithium inhibition of adrenaline stimulated adenylate cyclase in humans".
CURRENT AND PAST (LAST 5 YEARS) GRANT SUPPORT
From-To Title of project Sources and role
2010- The role of gene CD38 (Cyclic ADP-ribose hydrolase) Start-up grant, National 2012 in human social behavior University Singapore (NUS) Amount: SGD240,669 PI
2010- Decision Making under Urbanization: A HSS Grant, NUS 2012 Neurobiological and Experimental PI Economics Approach Amount: SGD200,000
2010- Biology of Decision Making under Risk AXA Research Foundation 2015 Amount: EURO517,000 RPE is PI CHEW is co-PI
2010- Biological Economics and Decision Making Tier 2 Ministry of Education 2013 Amount: SGD 1,237,000 Singapore CHEW PI, RPE co-PI
2010- Genes, God and Generosity: The Yin Yang of DNA and Templeton Foundation 2013 Culture RPE is PI Amount: USD200,000 CHEW is co-PI (ID: 21240)
2 Economics, Psychology and Neurobiology of Moral HSS Fund, R-122-000-208-646 014-2016 Decision Making CHEW and EBSTEIN are PIs Amount: SGD39,000
2014- Personality, Molecular Biomarkers and Successful Tier 2 Ministry of Education 2017 Ageing Singapore MOE2013-T2-1-047 Amount: SGD604,900 RPE is PI; A/Prof Ng Tze Pin is Co-PI 2015- Honesty, Humility, and Humanity: How the Epigenome Templeton World Charity 2018 and Mindfulness Shape Moral Decision Making Foundation Amount: USD999,824.95 RPE is PI
2015- Psychosocial, lifestyle, behavioural, biological and National Medical Research 2018 genetic determinants of healthy aging in the Singapore Council Longitudinal Aging Studies NG Tze Pin is PI Amount: SGD1,499,750 RPE is Co-PI 2015- The neurogenetic of decision making under stress MOE Tier 1 2018 Amount: SGD98,000 YU Rongjun is PI RPE is Co-PI
2016- Can social touch in the media shape a culture's MOE Tier 1 2018 sociality? RPE is PI Amount: SGD92,000
PRINCIPAL COLLABORATORS Prof. Chew Soo Hong, National University of Singapore Dr. So Ng Tze Pin, Department of Psychological Medicine Dr. Zhong Songfa, National University of Singapore A/Prof. Lai Poh San, National University of Singapore Dr. C.C. Khor, Genomic’s Institute of Singapore A/Prof. Ming Hsu, University of California, Berkely Prof. Markus Heinrichs, University of Freiburg Prof. Steve Faraone, SUNY Syracuse Prof. Nurit Yirmiya, Hebrew University A/Prof. Ariel Knafo, Hebrew University Prof. Eyal Winter, Rationality Center, Hebrew University Dr. Simone Shamay-Tsoory, Haifa University Prof. Ruth Feldman, Bar Ilan Univeristy
INVITED SYMPOSIUM/ POSTER PRESENTER Year 2016 Symposium on Neuroscience at HKU, Apr 2016: invited speaker 31st international congress of Psychology in Yokohama, Japan: invited speaker ICHG 2016 Kyoto International Congress of Human Genetics: poster presenter Year 2016 11th Asia Pacific Conference on Human Genetics in Hanoi, Vietnam: invited speaker 11th World Congress on Neurohypophysial Hormones in Queenstown, New Zealand, Aug-Sep 2015: poster presenter Year 2014 2014 International Cultural Neuroscience Consortium Conference Frontiers of Cultural Neuroscience, Neuroplasticity, Genetics, and Health University of Michigan, April 2014; invited speaker Invited lecture Fudan University, Shanghai, China May 2014 Invited lecture, University College London, June 2014 Invited lecture, University of Birmingham, June 2014 Invited lecture, Bristol University, June 2014 Invited lecture, Exeter University, June 2014 AXA RENDEZ-VOUS, Singapore, invited symposium speaker 2014 Work Shop on “The role of the unconscious in economic decision making” - Agalma Foundation in Geneva – Geneva, 2014; invited speaker 2014 CD38 and NAD A3 meeting Part II, Kanzawa JAPAN Nov 2014; invited symposium speaker Year 2013 King Abdullah University of Science and Technology WEP invited speaker, Jeddah, Saudi Arabia, Jan 16-23, 2013 Jacobs Foundation invited speaker “The Genetic Moderation of Intervention Efficacy” Marbach Castle, Germany 24-26 April, 2013 Dopamine 2013 invited speaker, Sardinia, Italy, 24-28 May, 2013Beijing National University and Peking University invited lecture, Beijing CHINA, 5-9 May, 2013 Bretts Annual Lecture 2013 invited lecturer, NUH, Singapore, Feb 23, 2013 MNS 2012 4th Conference of the Mediterranean Neuroscience Society. Invited speaker, Istanbul, Turkey, Sept 30-Oct 3 The 7th International Conference on Genomics & Bio-IT APAC 2012 invited speaker, Hong Kong, 28 Nov – Dec 1, 2012 Choice Symposium, Invited speaker, 9th Invitational Choice Symposium Workshop “Advancing Biological Understanding Of Economic And Consumer Decision-Making” 2 - 16 June, 2013 Huis ter Duin, Noordwijk, The Netherlands